A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)

Clinical trial NCT06885034 · RECRUITING

Trial details

NCT number: NCT06885034
Sponsor: GlaxoSmithKline
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Gastrointestinal Neoplasms

Start date: 2025-06-11
Primary completion: 2028-01-10
Enrollment: 451

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.